The efficacy and safety of selumetinib as secondary therapy for late-stage and metastatic non-small cell lung cancer: results from a systematic review and meta-analysis
@article{ATM95635, author = {Wei-Wei Wang and Wei-Qi Wang and Shan-Shan Wang and Lei Pan}, title = {The efficacy and safety of selumetinib as secondary therapy for late-stage and metastatic non-small cell lung cancer: results from a systematic review and meta-analysis}, journal = {Annals of Translational Medicine}, volume = {10}, number = {10}, year = {2022}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/95635} }